alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BIOMUNE
SYSTEMS, INC., DECEMBER 31, 1998, FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                         0000714634
<NAME>                        BIOMUNE SYSTEMS, INC.
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                   SEP-30-1998
<PERIOD-START>                      OCT-01-1998
<PERIOD-END>                        MAR-31-1999
<CASH>                                  202,346
<SECURITIES>                                  0     
<RECEIVABLES>                           710,268
<ALLOWANCES>                            145,019
<INVENTORY>                             174,591
<CURRENT-ASSETS>                      2,044,992
<PP&E>                                  128,941
<DEPRECIATION>                           70,218
<TOTAL-ASSETS>                        5,261,322
<CURRENT-LIABILITIES>                   237,257
<BONDS>                                       0
<PREFERRED-MANDATORY>                         0
<PREFERRED>                           2,428,638
<COMMON>                                    201
<OTHER-SE>                            2,595,226
<TOTAL-LIABILITY-AND-EQUITY>          5,261,322
<SALES>                               1,663,318
<TOTAL-REVENUES>                      1,663,318
<CGS>                                   672,125
<TOTAL-COSTS>                         1,657,550
<OTHER-EXPENSES>                              0
<LOSS-PROVISION>                              0
<INTEREST-EXPENSE>                            0
<INCOME-PRETAX>                         263,803
<INCOME-TAX>                                  0
<INCOME-CONTINUING>                     263,803
<DISCONTINUED>                                0
<EXTRAORDINARY>                               0
<CHANGES>                                     0
<NET-INCOME>                            263,803
<EPS-PRIMARY>                              0.18
<EPS-DILUTED>                              0.13
                            

</TABLE>
#### PALMER, Respondent, v. PALMER et al., Appellants.

(Supreme Court, Appellate Division, Third Department.

March 15, 1898.)

Action by Martha Palmer against Helen C. Palmer and others.

No opinion. Judgment affirmed, with costs.
I 

109TH CONGRESS 

1ST SESSION H. R. 2149 

To suspend temporarily the duty on Vullcanox 4010 NA/LG. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 5, 2005 

Mr. BROWN of South Carolina introduced the following bill; which was 

referred to the Committee on Ways and Means 

A BILL 

To suspend temporarily the duty on Vullcanox 4010 NA/ 

LG. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. VULLCANOX 4010 NA/LG. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.06.05 N-Isopropyl-N′-phenyl-pphenylenediamine (CAS No. 

101–72–4) (provided for in 

subheading 2921.51.50) ...... Free No change No change On or before 

12/31/2009 ’’. 
2 

•HR 2149 IH 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to goods entered, or withdrawn from 

3 warehouse for consumption, on or after the 15th day after 

4 the date of the enactment of this Act. 

Æ
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed).                    

*Date:*                         July 16, 2021.                    

*Time:*                         11:00 a.m. to 3:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3E70, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Mohammed S. Aiyegbo, Ph.D., Contract Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3E70, Rockville, MD 20852, (301) 761-7106,                         *mohammed.aiyegbo@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

      ( print page 34246)    
Dated: June 23, 2021.

Tyeshia M. Roberson,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-13814 Filed 6-28-21; 8:45 am]

BILLING CODE 4140-01-P
# C_2008067EN.01000701.xml

| 12.3.2008 | EN | Official Journal of the European Union | C 67/7 |
| --- | --- | --- | --- |

12.3.2008

EN

Official Journal of the European Union

C 67/7

---

Non-opposition to a notified concentration

(Case COMP/M.5041 — Berkshire Hathaway/Marmon Holdings)

(Text with EEA relevance)

(2008/C 67/03)

On 6 March 2008, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32008M5041. EUR-Lex is the on-line access to European law (http://eur-lex.europa.eu). |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32008M5041. EUR-Lex is the on-line access to European law (http://eur-lex.europa.eu).

---
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Genomics and Bioinformatics Research: Stoneville, MS
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                                    Software
                People

                    Staff Listing
                                    Careers


        


                    About GBRU
                        GBRU Mission Statement
                                    GBRU History
                                    GBRU Image Gallery
                                    GBRU Scientific Computing Learning Center
                    GBRU Downloads
                        BMC Genomics P. Pachyrhizi Supplemental Data
                                    Rice Data
                                    UPIC Software
                                    Vica Software (github)Search small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Southeast Area Stoneville, Mississippi Genomics and Bioinformatics Research





- ARS News & Events
- AgResearch Magazine
- Image Gallery
- News
- GBRU Main Page
- GBRU Mission Statement
- GBRU History
- GBRU Image Gallery
- GBRU Scientific Computing Learning Center

Newsheadline bar No News.   ARS News Articles  USDA's Agricultural Research Service Honors Scientists of the YearApr 24, 2024


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Methods and Application of Food Composition Laboratory: Beltsville, MD
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    About MAFCLSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Northeast Area Beltsville, Maryland (BHNRC) Beltsville Human Nutrition Research Center Methods and Application of Food Composition Laboratory MAFCL site pages





- MAFCL Home Page
- About MAFCL
- AMR
- FNR
- FDC
- Database Resources
- Historic Documents

HISTORIC DOCUMENTS
  National Food and Nutrient Analysis Program
 Key Foods
 Retail Meats
 Measurement Conversion Tables
 Glossary
 USDA Handbook 74


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
EXHIBIT 32


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Quarterly Report on Form 10-QSB (the "Report") of
Home Director, Inc. (the "Company") for the three and six month periods Ended
June 30, 2007, each of the undersigned, Michael Liddle, the Chief Executive
Officer of the Company, Mark Stiving, the President of the Company and Daryl
Stemm, the Chief Financial Officer of the Company, hereby certifies pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of the undersigned's knowledge and belief:


     (1) the Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and


     (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


Dated: August 7, 2007                   /s/ Michael Liddle
                                        ----------------
                                        Michael Liddle,
                                        Chief Executive Officer

Dated: August 7, 2007                   /s/ Mark Stiving
                                        ----------------
                                        Mark Stiving,
                                        President

Dated: August 7, 2007                   /s/ Daryl Stemm
                                        ------------------
                                        Daryl Stemm,
                                        Chief Financial Officer




                                -----------------



A signed original of the written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission of its staff upon request.
# L_2009172EN.01003501.xml

| 2.7.2009 | EN | Official Journal of the European Union | L 172/35 |
| --- | --- | --- | --- |

2.7.2009

EN

Official Journal of the European Union

L 172/35

---

DECISION OF THE EUROPEAN CENTRAL BANK

of 25 June 2009

amending Decision ECB/2008/20 as regards the volume of euro coins that Austria may issue in 2009

(ECB/2009/15)

(2009/508/EC)

THE GOVERNING COUNCIL OF THE EUROPEAN CENTRAL BANK,

Having regard to the Treaty establishing the European Community, and in particular Article 106(2) thereof,

Whereas:

| (1) | The European Central Bank (ECB) has the exclusive right from 1 January 1999 to approve the volume of coins issued by the Member States that have adopted the euro (hereinafter the ‘participating Member States’). |
| --- | --- |

(1)

The European Central Bank (ECB) has the exclusive right from 1 January 1999 to approve the volume of coins issued by the Member States that have adopted the euro (hereinafter the ‘participating Member States’).

| (2) | On 26 May 2009 the Oesterreichische Nationalbank asked the ECB to approve an increase of EUR 160 million in the volume of euro coins that Austria may issue in 2009, |
| --- | --- |

(2)

On 26 May 2009 the Oesterreichische Nationalbank asked the ECB to approve an increase of EUR 160 million in the volume of euro coins that Austria may issue in 2009,

HAS ADOPTED THIS DECISION:

Article 1

Increase in volume of euro coins

The ECB approves the increase in the volume of euro coins that Austria may issue in 2009.

As a result, the table in Article 1 of Decision ECB/2008/20 of the European Central Bank (1) is replaced by the following:

1

| (million EUR) |
| --- |
| | ‘Issuance of coins intended for circulation and issuance of collector coins (not intended for circulation) in 2009 |
| Belgium | 105,4 |
| Germany | 632,0 |
| Ireland | 65,5 |
| Greece | 85,7 |
| Spain | 390,0 |
| France | 252,5 |
| Italy | 234,3 |
| Cyprus | 22,5 |
| Luxembourg | 42,0 |
| Malta | 15,4 |
| Netherlands | 68,5 |
| Austria | 376,0 |
| Portugal | 50,0 |
| Slovenia | 27,0 |
| Slovakia | 131,0 |
| Finland | 60,0 ’ |

(million EUR)

‘Issuance of coins intended for circulation and issuance of collector coins (not intended for circulation) in 2009

Belgium

105,4

Germany

632,0

Ireland

65,5

Greece

85,7

Spain

390,0

France

252,5

Italy

234,3

Cyprus

22,5

Luxembourg

42,0

Malta

15,4

Netherlands

68,5

Austria

376,0

Portugal

50,0

Slovenia

27,0

Slovakia

131,0

Finland

60,0 ’

Article 2

Final provision

This Decision is addressed to the participating Member States.

Done at Frankfurt am Main, 25 June 2009.

The President of the ECB

Jean-Claude TRICHET

---

(1)  
  OJ L 352, 31.12.2008, p. 58.

1

---
Exhibit 4.7


 


[SB Financial Group, Inc. Letterhead]


 


March 6, 2015


 


Securities and Exchange Commission


100 F Street, NE


Washington, D.C. 20549


 


		Re:	SB Financial Group, Inc. – Annual Report on Form 10-K for the fiscal year ended December 31, 2014



 


Ladies and Gentlemen:


 


SB Financial Group, Inc., an Ohio corporation
(“SB Financial”), is today filing with the Securities and Exchange Commission (the “SEC”) the Annual Report
on Form 10-K of SB Financial for the fiscal year ended December 31, 2014 (“SB Financial’s 2014 Form 10-K”).


 


Pursuant to the instructions relating to the
Exhibits in Item 601(b)(4)(iii) of Regulation S-K, SB Financial hereby agrees to furnish to the SEC, upon request, copies of instruments
and agreements defining the rights of holders of long-term debt and of the long-term debt of its consolidated subsidiaries, which
are not being filed as exhibits to SB Financial’s 2014 Form 10-K. None of such long-term debt exceeds 10% of the total assets
of SB Financial and its subsidiaries on a consolidated basis.


 





	 	Very truly yours,
	 	 
	 	SB FINANCIAL GROUP, INC.
	 	 
	 	/s/ Anthony V. Cosentino
	 	Anthony V. Cosentino
	 	Executive Vice President and
	 	Chief Financial Officer
[Federal Register Volume 86, Number 122 (Tuesday, June 29, 2021)]
[Notices]
[Pages 34245-34246]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13814]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Understanding Evolutionary Dynamics 
of Influenza to Inform and Improve Vaccine Strain Selection (R01 
Clinical Trial Not Allowed).
    Date: July 16, 2021.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3E70, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Mohammed S. Aiyegbo, Ph.D., Contract Scientific 
Review Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3E70, 
Rockville, MD 20852, (301) 761-7106, <a href="/cdn-cgi/l/email-protection#c4a9abaca5a9a9a1a0eaa5adbda1a3a6ab84aaadaceaa3abb2"><span class="__cf_email__" data-cfemail="c3aeacaba2aeaea6a7eda2aabaa6a4a1ac83adaaabeda4acb5">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


[[Page 34246]]


    Dated: June 23, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-13814 Filed 6-28-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
‘ ~

+ > H
_ STATE OFINDIANA |

) IN THE NOBL, SUPERIOR COURT
) Ss: DIVISION 1
COUNTY OF NOBLE )
CAUSE NO. 57D01-0906-FD-122
STATE OF INDIANA )
)
Vv )
)
JEFFERY SCOTT BROWN )

SENTENCING ORDER

Comes Now the State of Indiana by Chief Deputy Prosecuting Attorney James Mowery and
the Defendant, Jeffery Scott Brown, in person and with counsel Howard Hanson and in
custody of the Noble County Sheriff's Department. The Court being duly advised now finds
and orders as follows as per the plea agreement:

WHEREAS the Defendant, Jeffery Scott Brown, has this day been adjudged guilty on his
plea of guilty by the Noble Superior Court, Division 1 of the crime of Ct 3 - Failure To
Register With Sex Offender Registry, Class D Felony, he is sentenced as follows:

Count I:

The Defendant shall be imprisoned in the Indiana Department of Correction
for a period of 6 months, allowing 82 days credit (41 days time served + 41
days Class 1 good time credif) for time heretofore spent in incarceration.
This sentence is consecutive to any sentence imposed in 43D01-9608-CE-227,
as such is required by I.C. 35-50-1-2(d).

The Defendant is ordered to pay a fine in the amount of $0.00 and Court
costs in the amount of $165.00.

The reason for the imposition of this sentence is that it is the one called for in the
Plea Agreement filed with this Court and is signed by the Prosecuting Attorney and
the Defendant and which the Court has accepted. The Court is, therefore, bound to
impose it.

The Defendant, being indigent, shall not be imprisoned for failure to pay fine
or costs, but they will be entered of record in the judgement docket.

On motion of the State, Counts 1 and 2. are dismissed.

EXHIBIT

iD

NOBLE CO SHERIFF 0009


+ a :
The Defendant is remanded to the Noble County Sheriff's Deparoment for execution of the
sentence. :

SO ORDERED THIS 11" DAY OF OCTOBER, 2011.

Rotor Kinch

Robert E. Kirsch, Judge
Noble County Superior Court, Division 1

NOBLE CO SHERIFF 0010